Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 1
2001 2
2002 2
2003 4
2005 4
2006 1
2007 5
2008 4
2009 4
2010 2
2011 6
2012 5
2013 4
2014 1
2015 6
2016 2
2017 2
2018 6
2019 6
2020 6
2021 10
2022 8
2023 3
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Low-dose-rate brachytherapy for low-grade prostate cancer.
Raabe NK, Normann M, Lilleby W. Raabe NK, et al. Among authors: lilleby w. Tidsskr Nor Laegeforen. 2015 Mar 24;135(6):548-52. doi: 10.4045/tidsskr.13.1404. eCollection 2015 Mar 24. Tidsskr Nor Laegeforen. 2015. PMID: 25806763 Free article. English, Norwegian.
Chemotherapy in metastatic renal cell cancer.
Lilleby W, Fosså SD. Lilleby W, et al. World J Urol. 2005 Jul;23(3):175-9. doi: 10.1007/s00345-004-0469-x. Epub 2005 Feb 22. World J Urol. 2005. PMID: 15726382 Review.
Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement.
Fletcher EAK, Cordfunke RA, Nasi A, Törnqvist G, Valentijn RRPM, Bergqvist A, Westhrin M, Rasch W, Lindqvist F, Dillmann I, Lord M, Bouwman N, Neefjes JJ, Franken KLMC, McArdle S, Ahmad M, Johansson S, Ossendorp F, Haggman M, Lampinen M, Ullenhag G, Ladjevardi S, Leja-Jarblad J, Lilleby W, Drijfhout JW, Mangsbo SM. Fletcher EAK, et al. Among authors: lilleby w. Mol Ther Oncol. 2025 Feb 20;33(2):200954. doi: 10.1016/j.omton.2025.200954. eCollection 2025 Jun 18. Mol Ther Oncol. 2025. PMID: 40520577 Free PMC article.
[Treatment of hormone-resistant prostate cancer].
Lilleby W, Hernes E, Waehre H, Raabe N, Fosså SD. Lilleby W, et al. Tidsskr Nor Laegeforen. 2006 Nov 2;126(21):2798-801. Tidsskr Nor Laegeforen. 2006. PMID: 17086220 Free article. Review. Norwegian.
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.
Philipson RG, Romero T, Wong JK, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Valle L, Chong N, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Tilki D, Karnes RJ, Klein EA, Tosoian JJ, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Kupelian PA, Rettig MB, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Kishan AU. Philipson RG, et al. Among authors: lilleby wa. Eur Urol. 2021 Aug;80(2):142-146. doi: 10.1016/j.eururo.2021.04.035. Epub 2021 May 10. Eur Urol. 2021. PMID: 33985797 Free PMC article.
85 results